Clinical response of nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs
Hahn, K.A.; Knapp, D.W.; Richardson, R.C.; Matlock, C.L.
Journal of the American Veterinary Medical Association 200(3): 355-357
1992
ISSN/ISBN: 0003-1488 PMID: 1548172 Document Number: 391400
In 11 dogs with nasal adenocarcinoma, IV treatment with 2 to 8 cycles of cisplatin at a dosage of 60 mg/m2 of body surface, given at 3-week intervals, resulted in a survival time of 8 to 128 weeks (mean, 32.7 weeks; median, 20 weeks). Radiography revealed complete remission in 2 dogs and partial remission in 1 dog, for an overall response rate of 27%. Clinical problems such as nasal discharge (n = 11), sneezing (n = 6), and epistaxis (n = 4) resolved in 1 to 2 weeks in all dogs after beginning chemotherapy.
Document emailed within 1 workday
Related Documents
Kim, Y.; Hata, T.; Tanizaki, K.; Okano, M.; Kawada, J.; Okuyama, M.; Yamasaki, M.; Murakami, M.; Shimizu, J.; Miwa, H.; Imamoto, H.; Tsujinaka, T. 2019: A Case of Liver Metastasis of Intrahepatic Cholangiocarcinoma that Achieved Clinical Complete Response after Gemcitabine and Cisplatin Combination Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(2): 360-362Hahn, K.A.; Matlock, C.L. 1990: Nasal adenocarcinoma metastatic to bone in two dogs Journal of the American Veterinary Medical Association 197(4): 491-494
Hara, K.; Iwasaka, T. 2004: Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 201-204
Kraegel, S.A.; Madewell, B.R.; Simonson, E.; Gregory, C.R. 1991: Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989) Journal of the American Veterinary Medical Association 199(8): 1057-1059
Yanagawa, T.; Bando, T.; Walid, A.; Yoshida, H.; Sato, M. 1988: The experimental chemotherapy by the combination of cisplatin and UFT on Human salivary gland adenocarcinoma grown in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(11): 3159-3161
Sasaki, K.; Hirata, K.; Denno, R.; Oikawa, I.; Mukaiya, M.; Hiraike, N.; Yagihashi, A.; Takasaka, H.; Katsuramaki, T.; Yamashiro, K.; Yamamitsu, S.; Shirasaka, T. 1997: Combination chemotherapy of continuous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(8): 959-964
Kitayama, S.; Iwahashi, M.; Iwahashi, M.; Yamoto, M.; Nakano, R. 1989: A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 2099-2101
Greco, F.A.; Hainsworth, J.D. 1994: Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy Seminars in Oncology 21(5 Suppl 12: 77-82
Vrdoljak, E.; Boraska Jelavic, T.; Saratlija-Novakovic, Z.; Hamm, W. 2005: Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in the treatment of locally advanced adenocarcinoma or adenosquamous carcinoma of the cervix uteri European Journal of Gynaecological Oncology 26(6): 602-604
Kohira, Y.; Ishibashi, Y.; Egawa, H.; Yube, Y.; Kaji, S.; Kanda, S.; Oka, S.; Kajiyama, Y.; Sakamoto, K.; Fukunaga, T. 2019: A Case of Advanced Gastric Cancer with Pathological Complete Response after Chemotherapy(S-1/Cisplatin) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 929-931
Soh, S.; Uchida, T.; Mukai, N.; Rokkaku, S.; Koshiba, K. 1994: Leiomyosarcoma of the prostate: response to treatment with cisplatin, etoposide and methotrexate chemotherapy: a case report Hinyokika Kiyo. Acta Urologica Japonica 40(1): 83-85
Zhang, M-Chun.; Hu, C-Ping.; Chen, Q. 2006: Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells Zhonghua Zhong Liu Za Zhi 28(6): 408-412
Caracciolo, G.; Vicedomini, D.; Di Blasi, A.; Indolfi, P.; Casale, F.; De Dominicis, G.; Saggiomo, G.; Greco, N. 1995: Adenocarcinoma of the pancreas in childhood (pancreatoblastoma): report of a case with good response to chemotherapy Tumori 81(5): 391-394
Nishino, T.; Yamamoto, Y.; Ikeda, M.; Morimoto, M.; Furukawa, T.; Goto, M.; Furukita, Y.; Takechi, H.; Seike, J.; Tangoku, A.; Fujiwara, H. 2013: Pathological complete response in a case of advanced esophageal cancer invading aorta treated by preoperative chemotherapy with docetaxel and cisplatin plus 5-FU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(5): 643-646
Pelikan, Z.; Pelikan-Filipek, M. 1995: Late nasal response to allergen challenge cytologic changes in the nasal secretions and histologic changes in the nasal mucosa Advances in Experimental Medicine and Biology 371b: 855-860
Kubota, Y.; Nakano, M.; Nagai, S.; Matsuoka, K.; Arakawa, H.; Horie, K.; Deguchi, T.; Kato, H. 2015: Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report Hinyokika Kiyo. Acta Urologica Japonica 61(1): 33-37
Kumano, M.; Miyake, H.; Hara, I.; Muramaki, M.; Takenaka, A.; Fujisawa, M. 2007: Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy Hinyokika Kiyo. Acta Urologica Japonica 53(12): 851-856
Corbett, T.H.; Griswold, D.P.; Roberts, B.J.; Peckham, J.C.; Schabel, F.M. 1978: Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy Cancer Treatment Reports 62(10): 1471-1488
Makhnova, E.V. 2003: Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer Voprosy Onkologii 49(1): 60-65
Teraishi, F.; Uno, F.; Kagawa, S.; Gochi, A.; Fujiwara, T.; Tanaka, N. 2006: A case report--The marked response to gemcitabine combined with irinotecan and low-dose cisplatin chemotherapy for advanced gastric cancer with multiple liver metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(12): 1885-1887